Breast Cancer Clinical Trial

Clinical Trial Finder Breast Cancer Trials

Breast VCEUS to Evaluate Early Response to Neoadjuvant Chemotherapy

See Locations Near You

Summary

Evaluate quantitative VCEUS imaging for determining early breast cancer response to neoadjuvant chemotherapy and compare results to co-temporal volume change on grayscale ultrasound and post-treatment mammography findings utilizing final surgical pathology and clinical outcome.
Assess incremental benefit of quantitative VCEUS to planar CEUS tumor perfusion measurements and enhancement patterns in predicting tumor response to adjuvant treatment in clinical studies.

The contrast agent Definity® is FDA approved for use as a contrast agent during ultrasound (echocardiography) of the heart. Definity® will be used "off-label" (during ultrasound of the breast) in this study. The administration of Definity® during this study will follow total dose guidelines approved by the FDA.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Adult patients (age 19 years or older).
Patients with newly diagnosed and untreated stage II and III breast cancer scheduled to undergo neoadjuvant chemotherapy.
Patients with signed informed consent.

Exclusion Criteria:

Any history of prior radiation or chemotherapy for breast cancer.
Patients who only have non-measurable disease.
Patients who are medically unstable.
Patients with other primary cancers requiring systemic treatment.
Patients with cardiac shunts.
Patients with unstable cardiopulmonary conditions.
Patients with known pulmonary hypertension.
Patients with known hypersensitivity to any component of Definity (R) microbubble contrast.
Patients who are pregnant, breast-feeding or are planning to become pregnant during the study duration.

Study is for people with:

Breast Cancer

Estimated Enrollment:

6

Study ID:

NCT01817374

Recruitment Status:

Terminated

Sponsor:

University of Alabama at Birmingham

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Alabama at Birmingham
Birmingham Alabama, 35294, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

6

Study ID:

NCT01817374

Recruitment Status:

Terminated

Sponsor:


University of Alabama at Birmingham

How clear is this clinincal trial information?

Clinical Trial Resources

SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials for Breast Cancer
Have You Been Diagnosed With Late-Stage Breast Cancer? Know That You Have Treatment Options.
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider